Understanding APC - malecare.org

Morbidity and Treatment Regret in Men with Recurrent Prostate Cancer

Researchers wanted to determine if concurrent the development of morbidity issues ( i.e.- myocardial infarction, congestive heart failure, angina, diabetes, stroke, circulation problems, inflammatory bowel disease, or amputation) is associated with treatment regret among men with PSA recurrence following failed primary therapy for prostate cancer. The researchers evaluated 795 men from the Comprehensive, Observational, Multicenter, [...]

By Malecare|2017-10-19T10:53:17-04:00February 24th, 2011|Advanced Prostate Cancer, Drugs & Treatments, General Information, Prostate Ponderings, Research, Uncategorized, Understanding APC|0 Comments

A phase III Trial Comparing Intermittent versus Continuous ADT for Men with PSA Progression after Radiotherapy

In prior studies with men who have had a PSA recurrence after radiotherapy (RT), intermittent androgen suppression (IAS) has been suggested to improve quality of life (QoL) but effects on survival are unknown. The researchers performed an inter-group randomized phase III trial, which compared IAS vs continuous androgen deprivation (CAD) to test overall survival (OS) [...]

By Malecare|2011-02-22T11:11:47-05:00February 22nd, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, Radiotherapy, Uncategorized, Understanding APC|0 Comments

Caution- Do Not Combine Chemotherapy for Prostate Cancer with Avestin

An article appearing today the Urology Times E-News rang a warning bell about the use of the angiogenesis inhibitor bevacizumab (Avastin). The article warned that men with advanced prostate cancer may be at an increased risk of treatment-related death when bevacizumab is used in combination with other therapies. Senior author Shenhong Wu, MD, PhD, and [...]

By Malecare|2011-02-18T11:57:00-05:00February 18th, 2011|Advanced Prostate Cancer, Cabazitaxel, Chemo Therapy, Chemo Therapy Failure, Drugs & Treatments, General Information, Research, Uncategorized, Understanding APC|0 Comments

The effect of PSA doubling time (PSADT) and Gleason score on the PSA at the time of initial metastasis in men with biochemical recurrence after prostatectomy.

The researchers took a cohort of 430 men with a biochemical recurrence (PSA increase only) after failed prostatectomy. The men underwent observation until they experienced metastatic disease as determined by CT or bone scan. The researchers then evaluated the PSA at the time the men developed metastasis for those patients who developed metastatic disease. PSA [...]

By Malecare|2017-10-19T10:53:17-04:00February 17th, 2011|Advanced Prostate Cancer, General Information, Metastases, Research, Uncategorized, Understanding APC|2 Comments

Pomegranate Effects PSADT in Men with Advanced Prostate Cancer

Prostate cancer diets and the use of supplements have continued to be an issue faced by men fighting advanced prostate cancer. Different products seem to fall in and out of vogue; unfortunately we usually have little actual hard data on the real value of any of these products. The use of pomegranate with the goal [...]

By Malecare|2020-02-04T10:13:14-05:00February 16th, 2011|Advanced Prostate Cancer, Diet and Supplements, Drugs & Treatments, FDA, General Information, Me, Research, Uncategorized, Understanding APC|7 Comments